Karen L. Smith, Director at ACCELERON PHARMA INC (XLRN), sold 23,728 shares at $140.13 ($3.3M) on 2021-04-05, disclosed to the SEC on 2021-04-05.
Open-market sale of $3.3M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.13 | 11,223 | $1.6M | 47.3% |
| 2 | $140.13 | 11,223 | $1.6M | 47.3% |
| 3 | $141.15 | 641 | $90K | 2.7% |
| 4 | $141.15 | 641 | $90K | 2.7% |
| Total | $140.19 avg | 23,728 | $3.3M | 100% |
| Filing → |
| JAZZ | BUY | 2016-08-12 | $167K | — | Filing → |
| JAZZ | BUY | 2016-07-13 | $167K | — | Filing → |
| JAZZ | BUY | 2016-06-15 | $167K | — | Filing → |